Frontlight ResearchEarly access
Trial site
Hospital Clinico Universitario Virgen de La Victoria
- 9running trials
- 17closed trials
The trials here
What the 26 trials at this site are about, from their registry records.
- Conditions
- Lung cancer5 trials
- Metastatic breast cancer5 trials
- Triple-negative breast cancer4 trials
- Colorectal cancer3 trials
- Heart failure3 trials
- Liver and biliary tract cancer3 trials
- Ovarian cancer3 trials
- Prostate cancer3 trials
- Head and neck cancer2 trials
- Kidney cancer2 trials
- Melanoma2 trials
- Obesity2 trials
- and 8 more
- Phase
- Phase 313 trials
- Phase 25 trials
- Phase 13 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Status
- Completed11 trials
- Terminated6 trials
- Active, not recruiting4 trials
- Recruiting4 trials
- Not yet recruiting1 trial
- Lead sponsor
- Hoffmann-La Roche9 trials
- Amgen5 trials
- Daiichi Sankyo3 trials
- Bristol-Myers Squibb1 trial
- GBG Forschungs GmbH1 trial
- and 7 more
Running trials
Recruiting
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Sacituzumab Govitecan in Primary HER2-negative Breast Cancer
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute lymphoblastic leukaemia1 recruiting
- Heart failure1 recruiting
- Hypertrophic cardiomyopathy1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Prostate cancer1 recruiting
Closed trials
Recruiting
Terminated
Terminated
Terminated
Completed
Terminated
Completed
Completed
Completed
Completed
Completed
MEN1611 With Trastuzumab (+/- Fulvestrant) in Metastatic Breast Cancer
Completed
Completed
Terminated
Completed
Completed
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026